Cargando…

The Potential Benefits of HPV E6/E7 mRNA Test in Cervical Cancer Screening in China

This study aims to evaluate the clinical performance of the HPV E6/E7 mRNA test in cervical cancer screening in China. A hospital-based study was conducted with mRNA, DNA, and liquid-based cytology (LBC) as primary screening tests. Each woman with a positive result received colposcopy with lesion-ta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Shao-Kai, Guo, Zhen, Wang, Peng, Kang, Le-Ni, Jia, Man-Man, Wu, Ze-Ni, Chen, Qiong, Cao, Xiao-Qin, Zhao, Dong-Mei, Guo, Pei-Pei, Sun, Xi-Bin, Zhang, Jian-Gong, Qiao, You-Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567165/ https://www.ncbi.nlm.nih.gov/pubmed/33123463 http://dx.doi.org/10.3389/fonc.2020.533253

Ejemplares similares

Performance of Different Combination Models of High-Risk HPV Genotyping in Triaging Chinese Women With Atypical Squamous Cells of Undetermined Significance
por: Guo, Zhen, et al.
Publicado: (2019)

The Risk Stratification for Cervical Cancer and Precursors of Domestic HPV Testing With HPV 16/18 Genotyping in Women With NILM Cytology in CentralChina: A Cohort Study
por: Xu, Hui-Fang, et al.
Publicado: (2021)

HPV16 E6 Promotes the Progression of HPV Infection-Associated Cervical Cancer by Upregulating Glucose-6-Phosphate Dehydrogenase Expression
por: Chang, Ye-Fei, et al.
Publicado: (2021)

The Expression of HPV E6/E7 mRNA In Situ Hybridization in HPV Typing-negative Cervical Cancer
por: Xu, Yating, et al.
Publicado: (2023)

hnRNP E1 Regulates HPV16 Oncogene Expression and Inhibits Cervical Cancerization
por: Song, Li, et al.
Publicado: (2022)

Construction of an immune-related ceRNA network in cervical cancer based on HPV E6 splicing
por: Jiang, Senwei, et al.
Publicado: (2022)

E2F2/5/8 Serve as Potential Prognostic Biomarkers and Targets for Human Ovarian Cancer
por: Zhou, Quan, et al.
Publicado: (2019)

Delineation of the HPV11E6 and HPV18E6 Pathways in Initiating Cellular Transformation
por: Mwapagha, Lamech M., et al.
Publicado: (2017)

HPV16 E7 oncoprotein test as a triage strategy for HPV16-positive women in cervical cancer screening: long-term follow-up outcome
por: Wang, Xinmei, et al.
Publicado: (2023)

Diagnostic Utility of HPV16 E6 mRNA or E7 mRNA Quantitative Expression for Cervical Cells of Patients with Dysplasia and Carcinoma
por: Wu, Ming-Zhe, et al.
Publicado: (2018)

Nimotuzumab Combined With Irradiation Enhances the Inhibition to the HPV16 E6-Promoted Growth of Cervical Squamous Cell Carcinoma
por: Xu, Zhonghua, et al.
Publicado: (2020)

Predictive Value of HPV E6/E7 mRNA Detection on the Outcome of Cervical LSIL
por: Cao, Limei, et al.
Publicado: (2022)

Implications of Persistent HPV52 and HPV58 Positivity for the Management of Cervical Lesions
por: Yi, Baozhu, et al.
Publicado: (2022)

Retracted: Predictive Value of HPV E6/E7 mRNA Detection on the Outcome of Cervical LSIL
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

High-Risk HPV16 E6 Activates the cGMP/PKG Pathway Through Glycosyltransferase ST6GAL1 in Cervical Cancer Cells
por: Wang, Jun, et al.
Publicado: (2021)

Accuracy of HPV E6/E7 mRNA examination using in situ hybridization in diagnosing cervical intraepithelial lesions
por: Hui, Chang, et al.
Publicado: (2021)

Dietary Polyphenols, Resveratrol and Pterostilbene Exhibit Antitumor Activity on an HPV E6-Positive Cervical Cancer Model: An in vitro and in vivo Analysis
por: Chatterjee, Kaushiki, et al.
Publicado: (2019)

HPV E6/E7 mRNA in situ hybridization in endocervical adenocarcinoma: implications for prognosis and diagnosis
por: Luo, Rong-Zhen, et al.
Publicado: (2021)

HPV16 E6-Activated OCT4 Promotes Cervical Cancer Progression by Suppressing p53 Expression via Co-Repressor NCOR1
por: Shu, Shujuan, et al.
Publicado: (2022)

HPV E6, E6AP and cervical cancer
por: Beaudenon, Sylvie, et al.
Publicado: (2008)

Association of cervical carcinogenesis risk with HPV16 E6 and E7 variants in the Taizhou area, China
por: Dai, Mei-Zhen, et al.
Publicado: (2021)

Better or Worse? The Independent Prognostic Role of HPV-16 or HPV-18 Positivity in Patients With Cervical Cancer: A Meta-Analysis and Systematic Review
por: Chen, Xing, et al.
Publicado: (2020)

Monoclonal antibodies in cervical malignancy-related HPV
por: Aghbash, Parisa Shiri, et al.
Publicado: (2022)

HPV genotype determination and E6/E7 mRNA detection for management of HPV positive women
por: Bruno, Maria Teresa, et al.
Publicado: (2018)

CXCL12 and CD3E as Indicators for Tumor Microenvironment Modulation in Bladder Cancer and Their Correlations With Immune Infiltration and Molecular Subtypes
por: Liu, Yi, et al.
Publicado: (2021)

Effect of β-sitosterol on the expression of HPV E6 and p53 in cervical carcinoma cells
por: Cheng, Dali, et al.
Publicado: (2015)

Performance of p16/Ki67 immunostaining, HPV E6/E7 mRNA testing, and HPV DNA assay to detect high-grade cervical dysplasia in women with ASCUS
por: Zhu, Yuanhang, et al.
Publicado: (2019)

Performance of Aptima HPV E6/E7 mRNA Test for Detection of Cervical Lesions in a Large Chinese Population
por: Yang, Zhujuan, et al.
Publicado: (2022)

HPV16 E6/E7 -based mRNA vaccine is therapeutic in mice bearing aggressive HPV-positive lesions
por: Zhou, Kun, et al.
Publicado: (2023)

Role of HPV16 E1 in cervical carcinogenesis
por: Baedyananda, Fern, et al.
Publicado: (2022)

Diagnostic value of high-risk HPV E6/E7 mRNA in patients with ASCUS
por: Jin, Xiu, et al.
Publicado: (2023)

Development and Validation of Prognostic Nomograms Based on Gross Tumor Volume and Cervical Nodal Volume for Nasopharyngeal Carcinoma Patients With Concurrent Chemoradiotherapy
por: Zhang, Cui-Dai, et al.
Publicado: (2021)

Retrieval of HPV oncogenes E6 and E7 mRNA from cervical specimens using a manual open technology protocol
por: Campbell, Leonardo Martins, et al.
Publicado: (2013)

E6/E7 mRNA Expression of the Most Prevalent High-Risk HPV Genotypes in Cervical Samples from Serbian Women
por: Nikolic, Natasa, et al.
Publicado: (2023)

A novel HPV16 E7-affitoxin for targeted therapy of HPV16-induced human cervical cancer
por: Jiang, Pengfei, et al.
Publicado: (2018)

REBACIN(®) inhibits E6/E7 oncogenes in clearance of human papillomavirus infection
por: Zhou, Shu-Guang, et al.
Publicado: (2022)

HPV 16 E6/E7 Promote the Glucose Uptake of GLUT1 in Lung Cancer Through Downregulation of TXNIP Due to Inhibition of PTEN Phosphorylation
por: Tang, Jia-Yi, et al.
Publicado: (2020)

The Use of HPV16-E5, EGFR, and pEGFR as Prognostic Biomarkers for Oropharyngeal Cancer Patients
por: Taberna, Miren, et al.
Publicado: (2018)

HPV18 E7 induces the over-transcription of eIF4E gene in cervical cancer
por: Pang, Tianyun, et al.
Publicado: (2015)

HPV DNA methylation at the early promoter and E1/E2 integrity: A comparison between HPV16, HPV18 and HPV45 in cervical cancer
por: Amaro-Filho, Sérgio Menezes, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_thfic2unj02jkkmuu9ssbk13m8